Big pharma coming after the PBS is a compliment — it shows that the scheme works in the best interests of people, not the markets.

IAG Cargo’s Constant Climate cold chain solution that facilitates the transportation of pharmaceuticals, such as vaccines, ...

Preventive care—like routine screenings, vaccinations, and early interventions—saves lives and reduces healthcare costs in ...

The first time Dr. Fajgenbaum repurposed a drug, it was in an attempt to save his own life. At 25, while in medical school, ...

The key differentiator won't be AI itself but how effectively organizations harness it to create smarter and more efficient ...

Ravi Udaya Bhaskar said India needs to convey to the US ‘very clearly that the President cannot weaponise tariffs to bully ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

In a world overflowing with health information, it can be overwhelming to sift through the noise and find what truly matters ...

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of 1,400% and 273.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.

America's pharmaceutical giants have been plotting to torpedo the Australia's Pharmaceuticals Benefits Scheme, despite securing major concessions 20 years ago.